In the past two years, the Food and Drug Administration has approved two novel Alzheimer's therapies, based on data from clinical trials showing that both drugs slowed the progression of the disease.

Chronic obstructive pulmonary disease (COPD), a condition that affects more than 14 million U.S. adults, is marked by damage ...

We sifted through stock screeners, online rankings, and ETFs to compile a list of 30 cancer stocks. We then selected the top ...

Chronic obstructive pulmonary disease (COPD) is a manifestation of structural violence, the process through which societies ...

After diagnosing ACOS, your doctor will instruct you on how best to manage ... only asthma or COPD. ACOS is chronic and progressive, meaning symptoms can worsen over time. Treatment and disease ...

With the best LED face masks now repping technology ... “Red light is an anti-ageing treatment used to promote collagen production and to enhance skin elasticity,” Dr Nyla explains, while ...

For those with chronic conditions, such as COPD, a healthcare professional will work with the individual to help them breathe more easily. This will involve developing a treatment plan that helps ...

The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used as a standalone treatment for patients with severe depression ...

These symptoms are not typical for COPD. There’s no cure for COPD or IPF. But many similar treatments may help ease symptoms of either disease. Quit smoking. This is the first thing your doctor ...

The study included a 6-week screening period, 52 weeks of treatment, and a 12-week safety follow-up. The annualized rate of moderate or severe COPD exacerbations for 52 weeks was the primary endpoint.

and generally limit the toll which cancer treatment exerts on the human body. The home of these experiments is the European Laboratory for Particle Physics (Cern), best known to the world as the ...